<DOC>
	<DOCNO>NCT00258817</DOCNO>
	<brief_summary>To provide serum Food Drug Administration ( FDA ) use FDA , Centers Disease Control Prevention ( CDC ) , World Health Organization ( WHO ) characterization circulate influenza strain . Observational Objectives : To describe safety 2005-2006 pediatric formulation Fluzone vaccine , give two-dose schedule accordance Package Insert , child age ≥ 6 month &lt; 36 month . To describe immunogenicity 2005-2006 pediatric formulation Fluzone vaccine , administer two-dose schedule accordance Package Insert , child age ≥ 6 month &lt; 36 month .</brief_summary>
	<brief_title>Phase IV Trial Collect Safety Data Sera Healthy Children Given Fluzone Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participant age ≥ 6 month ( 24 week ) &lt; 36 month ( 3rd birthday ) . Participant consider good health basis report medical history limited physical examination . Participant available duration study . Parent/legal acceptable representative willing able provide inform consent . Parent/legal acceptable representative willing able meet protocol requirement . Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg . Reported allergy egg protein , chicken protein , constituent vaccine . Documented history influenza infection . An acute illness without fever ( temperature ≥ 100.4 °F , rectal ) 72 hour precede enrollment trial ( Enrollment may defer ) . Clinically significant finding vital sign review system ( investigator judgment ; defer exclude ) . Participation interventional clinical trial within 30 day prior enrollment termination subject 's participation study . Known suspect impairment immunologic function , receipt immunosuppressive therapy immunoglobulin since birth . Personal immediate family history congenital immune deficiency . Developmental delay , neurologic disorder , seizure disorder . Chronic medical , congenital , developmental disorder . Known Human immunodeficiency virus ( HIV ) positive mother . Prior history GuillainBarré syndrome . Any condition , opinion investigator , would pose health risk subject interfere evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fluzone®</keyword>
	<keyword>Influenza Virus Vaccine</keyword>
</DOC>